Enhancement of pharmacist role for the management of Chronic Obstructive Pulmonary Disease (COPD) in Pakistan

INTERVENTION: The study has two arms Arm 1: There will be only educational intervention provided to this group (COPD patients) by the principle investigator ( Counselling about the disease, correct use of medication and life style modification ( Diet and Exercise). This study group will receive the onging medication prescribed by the physician. Arm 2 : There will be a pharmacological intervention will be provided according to the GOLD guidelines as following step 1: The patients will be diagnosed following the standard procedure mentioned in GOLD guidelines. Step 2: Then pharmacological treatment will be given according to the GOLD guidelines Step 3: Educational intervention ( 30 minute face‐to‐face patient counselling) will be provided also as mentioned in Arm 1 Study Activities: 1: At the time of patient enrollment interventions will be provided to both groups 2: After every 2 months patients will be called for checking adherence to the interventions by interviewing the patients and by checking patient prescriptions and medications used by patients 3: The patients will be enrolled at Out patient department of ' Holy Family Hospital Rawalpindi, Pakistan' and interventions will be provided by the principle investigator 4 : The interventions will be provided only once 5: Response will be gathered after 6 months by checking disease state, patient quality of life and No. of acute exacerbation during this period of study CONDITION: Chronic obstructive pulmonary disease; ; Chronic obstructive pulmonary disease Respiratory ‐ Chronic obstructive pulmonary disease PRIMARY OUTCOME: ; No. of acute exacerbation will be assessed in intervention groups by using; a) Spirometry to check disease progression; b) No, of emergency hospital visits will be counted from patients medical record (prescriptions, lab reports etc), ; c) Quality of life will be measured by the St George's Respiratory Questionnaire; ; [24 weeks/ 6 months after interventions] Disease progression will be assessed by spirometery ; Forced expiratory volume (FEV1) for 1 sec will be measure before and after intervention to study the impact of interventions ; [After 24 weeks/ 6 months of intervention disease progression will be assessed] Quality of life assessed using the St. George's Respiratory Questionnaire[After 24 weeks/ 6 months of commencement of intervention the outcomes will be assessed ] SECONDARY OUTCOME: Mortality rate of intervention group will be compared [After 1 year of interventions ] INCLUSION CRITERIA: Patients only attend the outpatient COPD wards, confirmed diagnosis of COPD by the hospital consultant for at least 1 year with a forced expiratory volume in 1 s (FEV1) of 30–80% of the predicted normal value, patients that hospital consultant agree that the patient is suitable for entering the trial will be included in this study.